The validated data then passed through several rounds of quality control to remove errors and inconsistencies, so the final numbers reflect a consistent and defensible view of the market
Phase Weeks 1-2 Draw volume 7.5 units (0.075 mL) Total blend delivered ~2.0 mg total blend GHK-Cu ~1.25 mg KPV ~250 mcg BPC-157 ~250 mcg TB-500 ~250 mcg Phase Weeks 3-4 Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Phase Weeks 5-8 Draw volume 22.5 units (0.225 mL) Total blend delivered ~6.0 mg total blend GHK-Cu ~3.75 mg KPV ~750 mcg BPC-157 ~750 mcg TB-500 ~750 mcg Phase Weeks 9-12 (taper) Draw volume 15 units (0.15 mL) Total blend delivered ~4.0 mg total blend GHK-Cu ~2.5 mg KPV ~500 mcg BPC-157 ~500 mcg TB-500 ~500 mcg Blend ratio 50 / 10 / 10 / 10 mg GHK-Cu dominant Select a draw volume from the titration table above to see the approximate amount of each peptide delivered
10.3390/molecules21050616 170 LeeG.BaeH
Many patients experience gastrointestinal side effects and wonder whether digestive enzymes with Mounjaro can be safely combined
The SUSTAIN clinical trial program, encompassing multiple Phase III studies with thousands of patients, generated definitive efficacy and safety data
Carver JA, Rekas A, Thorn DC, et al Small heatshock proteins and clusterin: intra and extracellular molecular chaperones with a common mechanism of action and function
